Kare and Steffan Throw in The Lundbeck Towel!

kare will need all that money when he's defending himself in front of congress and the fda for his price rigging of northera

100's of northera reps will gladly confirm their price rigged program and that they priced it to where someone has to pay over 10,000 a month for a prescription. I am amazed those people on northera in the promotion material have not revolted as one would expect they can't afford this medicine at those prices. Maybe Kare can with all that money but seriously what person with any integrity could state they would find it ok for a patient to pay even 1000 a month for a drug, let alone 100,000+ a year. And wait for your insurance quote next year or your employer shitting themselves that their costs for coverage have gone up several times for 1 patient on northera.

 

What's most galling about the price is that this isn't a cure for cancer. You might feel less dizzy...

 

Even Epi pen is only $600/ month WAC. WTF were they thinking for a drug to prevent dizziness? No wonder the marketing team keeps turning over!

 

Look people, we have the best psychiatry pipeline in the industry. You don't even know about a third of the stuff we have in the pipeline yet. Relax. Lundbeck is well positioned to compete and own neuroscience.

 

The marketing team has been a revolving door.

This brand can't keep marketing and the new Northera support program is changing once again. You would think after onfi and it being retail this company could have made bank on just volume for retail.


We spent millions for long term care training and sent everyone at the time to nursing homes and omnicare. We paid consultant pharmacists and we have maybe .1% scripts because of cost. instead of 3000 active patients we could have had 30,000. Imagine if more docs had a chance to write if the drug didn't cost so
Much


This is what we get when a company rationalizes the price to lessen symptoms. Greed by these assholes at the top is what ruined a product that could help so many more


If Onfi used this treatment Form
Restriction we would have 5000 patients instead of over 100,000. Imagine what experience has been lost because we made it too hard to access.

At this point the sales force is disengaged because our changes are stickers to remove blood pressure offerings and there is zero new changes. When the company starts taking care of their people is when we will become engaged. Right now the company is on the downward spiral. The plane was a death trap and we flew it knowing that this work in progress was nothing but a mirage

 

The sarcasm is strong with this one. We have one psych drug being tested in humans (35700).

 

Lets hope the new senior leadership makes some positive changes if they want the company to thrive. Would have liked to see Steffan in charge but he is not a Dane!

 

Kare doing what he does best.... bullshit stories.. "strong" how about 14,000 layoffs in a hot economy....

https://www.cnbc.com/2018/02/08/teva-chief-reports-strong-progress-in-restructuring-plan.html

 

Teva and Lundbeck actually have quite a bit in common.

Weak future prospects due to poor pipeline and history of xenophobic leadership that led to investment in home nation workforce/HQ to the detriment of other country’s employees and the company as a whole.

We will see who survives longer. Kare’s reorg is a short term fix, similar to what he did at Lundbeck.

 

https://www.fiercepharma.com/pharma/less-than-one-year-into-job-action-oriented-teva-ceo-schultz-has-analysts-impressed

Continues to impress....is Lu ever going to find a new CEO? How long does it take to find someone willing to take the role?! What the hell are they waiting for? A goose that can lay a golden egg?!

 

That would be nice. It's obvious they can't find anyone with any real talent at running a company, because they realize just how bad the situation is at Lundbeck. If they took the job and failed, they would be branded for life as a failed CEO. They also don't seem to want PA at the helm. The biggest problem we have (outside of no pipeline) is poor lower management that are basically clueless on selling pharmaceuticals. They have so many ASM's that would never make it as reps. Also, forced ranking is the most demoralizing thing a company can do to a sales team. Many companies quit it years ago. Lundbeck needs to pull in neuro, reorg and give each manager 12 to 14 reps, quit the constant, useless ride-a-longs where they just piss off the docs and staff, give us better coverage, and see what happens.

I am beginning to think the ship is going to be very touch to turn around, at least with the management we now have. Something wicked this way comes.

 

Yep. That’s why 90% of those with talent left, starting around 2 years ago when it was clear nothing was being done to beef up the pipeline to replace Onfi and the other neuro products.

Only reason to stay now is pure laziness. Salaries here are low and pipeline is very limited.